A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B

• Published in: Journal of psychiatric research 2009-12, Vol.43 (16), p.1272-1277
• Main Authors: Houlihan, Lorna M, Christoforou, Andrea, Arbuckle, Margaret I, Torrance, Helen S, Anderson, Susan M, Muir, Walter J, Porteous, David J, Blackwood, Douglas H, Evans, Kathryn L
• Format: Article
• Language: English
• Subjects: Association; Bipolar affective disorder; Bipolar disorder; Bipolar Disorder - genetics; Case-Control Studies; Chromosome 4p15; Chromosomes; Expression studies; Family Health; Female; Gene Frequency; Genes; Genetic Predisposition to Disease; Genome-Wide Association Study - methods; Genotype; Humans; Male; Minor Histocompatibility Antigens; Phosphatidylinositol pathway; Phosphotransferases (Alcohol Group Acceptor) - genetics; Phosphotransferases (Alcohol Group Acceptor) - metabolism; PI4K2B; Polymorphism, Single Nucleotide - genetics; Psychiatry; Schizophrenia - genetics
• ISSN: 0022-3956; 1879-1379
• DOI: 10.1016/j.jpsychires.2009.05.004

Abstract Bipolar disorder, schizophrenia and recurrent major depression are complex psychiatric illnesses with a substantial, yet unknown genetic component. Linkage of bipolar disorder and recurrent major depression with markers on chromosome 4p15–p16 has been identified in a large Scottish family and three smaller families. Analysis of haplotypes in the four chromosome 4p-linked families, identified two regions, each shared by three of the four families, which are also supported by a case-control association study. The candidate gene phosphatidylinositol 4-kinase type-II beta ( PI4K2B ) lies within one of these regions. PI4K2B is a strong functional candidate as it is a member of the phosphatidylinositol pathway, which is targeted by lithium for therapeutic effect in bipolar disorder. Two approaches were undertaken to test the PI4K2B candidate gene as a susceptibility factor for psychiatric illness. First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder ( n = 368), schizophrenia ( n = 386) and controls ( n = 458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P = 0.005, permuted global P = 0.039). Second, expression studies at the allele-specific mRNA and protein level using lymphoblastoid cell lines from members of the large Scottish family, which showed linkage to 4p15–p16 in bipolar disorder and recurrent major depression, showed no difference in expression differences between affected and non-affected family members. There is no evidence to suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has not been excluded.